PMID- 30207783 OWN - NLM STAT- MEDLINE DCOM- 20191114 LR - 20200930 IS - 1522-1563 (Electronic) IS - 0363-6143 (Print) IS - 0363-6143 (Linking) VI - 316 IP - 1 DP - 2019 Jan 1 TI - Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes. PG - C2-C15 LID - 10.1152/ajpcell.00187.2018 [doi] AB - Transporters at the neurovascular unit (NVU) are vital for the regulation of normal brain physiology via ion, water, and nutrients movement. In ischemic stroke, the reduction of cerebral blood flow causes several complex pathophysiological changes in the brain, one of which includes alterations of the NVU transporters, which can exacerbate stroke outcome by increased brain edema (by altering ion, water, and glutamate transporters), altered energy metabolism (by altering glucose transporters), and enhanced drug toxicity (by altering efflux transporters). Smoking and diabetes are common risk factors as well as coexisting conditions in ischemic stroke that are also reported to change the expression and function of NVU transporters. Coexistence of these conditions could cause an additive effect in terms of the alterations of brain transporters that might lead to worsened ischemic stroke prognosis and recovery. In this review, we have discussed the effects of ischemic stroke, smoking, and diabetes on some essential NVU transporters and how the simultaneous presence of these conditions can affect the clinical outcome after an ischemic episode. Further scientific investigations are required to elucidate changes in NVU transport in cerebral ischemia, which can lead to better, personalized therapeutic interventions tailor-made for these comorbid conditions. FAU - Sifat, Ali E AU - Sifat AE AD - Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center , Amarillo, Texas. FAU - Vaidya, Bhuvaneshwar AU - Vaidya B AD - Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center , Amarillo, Texas. FAU - Villalba, Heidi AU - Villalba H AD - Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center , Amarillo, Texas. FAU - Albekairi, Thamer H AU - Albekairi TH AD - Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center , Amarillo, Texas. FAU - Abbruscato, Thomas J AU - Abbruscato TJ AD - Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center , Amarillo, Texas. LA - eng GR - R01 NS076012/NS/NINDS NIH HHS/United States GR - R01 DA029121/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20180912 PL - United States TA - Am J Physiol Cell Physiol JT - American journal of physiology. Cell physiology JID - 100901225 RN - 0 (Glucose Transport Proteins, Facilitative) RN - 0 (Membrane Transport Proteins) SB - IM MH - Animals MH - Blood-Brain Barrier/metabolism/pathology MH - Brain/metabolism/pathology MH - Brain Ischemia/*metabolism/pathology MH - Diabetes Mellitus/*metabolism/pathology MH - Glucose Transport Proteins, Facilitative/metabolism MH - Humans MH - Ion Transport/physiology MH - Membrane Transport Proteins/*metabolism MH - Neurons/metabolism/pathology MH - Neurovascular Coupling/*physiology MH - Smoking/*metabolism/pathology MH - Stroke/*metabolism/pathology PMC - PMC6383146 OTO - NOTNLM OT - glucose transporters OT - ion transporters OT - ischemic stroke OT - neurovascular unit EDAT- 2018/09/13 06:00 MHDA- 2019/11/15 06:00 PMCR- 2020/01/01 CRDT- 2018/09/13 06:00 PHST- 2018/09/13 06:00 [pubmed] PHST- 2019/11/15 06:00 [medline] PHST- 2018/09/13 06:00 [entrez] PHST- 2020/01/01 00:00 [pmc-release] AID - C-00187-2018 [pii] AID - 10.1152/ajpcell.00187.2018 [doi] PST - ppublish SO - Am J Physiol Cell Physiol. 2019 Jan 1;316(1):C2-C15. doi: 10.1152/ajpcell.00187.2018. Epub 2018 Sep 12.